PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--ForteBio, a division of Pall Life Sciences and a leading supplier of instrumentation for accelerated drug discovery and development, today announced the launch ...
Boston-based venture capital firm MPM Capital has participated in the $25 million Series C closing funding round of Menlo Park, Calif., company ForteBio Inc. ForteBio, an analytical systems provider ...
Octet and Multi-Analyte Software Tool Help Facilitate Development of Quantitation Assay Scientific projects are driven by the delivery of quality analytical data at the right time. The lack of robust ...
ForteBio is a Menlo Park, Calif. company that makes instruments for biomolecular analysis in the life sciences. Its instruments can measure proteins, DNA, RNA and other small molecules without the use ...
ForteBio accelerates discovery and development of vital medicines that cure diseases. We do that by enabling life science researchers to rapidly analyze molecules involved in biological processes, by ...